trans-Diaqua­bis(ethyl­enediamine-κ2 N,N′)copper(II) bis[3-(3-pyrid­yl)propionate] dihydrate

The asymmetric unit of the title complex, [Cu(C2H8N2)2(H2O)2](C8H8NO2)2·2H2O, contains one anion, one half-cation and one water mol­ecule. The CuII atom in the [Cu(en)2(H2O)2]2+ cation (en is ethyl­enediamine) lies on an inversion centre. The four N atoms of the en ligands in the equatorial plane around the CuII atom form a slightly distorted square-planar arrangement, while the slightly distorted Jahn–Teller octa­hedral coordination is completed by two water O atoms in axial positions. In the crystal structure, intra- and inter­molecular N—H⋯O and O—H⋯O hydrogen bonds form a three-dimensional network

Di-μ-nicotinato-κ2 N:O;κ2 O:N-bis­[aqua­(ethyl­enediamine-κ2 N,N′)(nicotinato-κN)cadmium(II)] dihydrate

The dinuclear mol­ecule of the title compound, [Cd2(C6H4NO2)4(C2H8N2)2(H2O)2]·2H2O, lies on an inversion centre and forms 12-membered (CdNC3O)2 metallacycles with the two Cd2+ ions bridged by two nicotinate ligands. Both Cd2+ ions display coordination polyhedra with a distorted octa­hedral geometry that includes two pyridine N atoms from bridging and terminal nicotinate anions, two amine N atoms from chelating ethylene­diamine ligands, carboxylate O atoms from bridging nicotinate anions and water O atoms. Inter­molecular O—H⋯O and N—H⋯O hydrogen bonds result in the formation of a three-dimensional network, and π–π stacking inter­actions are observed between symmetry-related pyridine rings of bridging as well as terminal nicotinate anions (the centroid–centroid distances are 3.59 and 3.69 Å, respectively, and the distances between parallel planes of the stacked pyridine rings are 3.53 and 3.43 Å, respectively). The two methylene groups of the ethylene­diamine ligand are disordered over two positions; the site occupancy factors are ca 0.8 and 0.2

Etiology of Pediatric Bacterial Meningitis Pre- and Post-PCV13 Introduction Among Children Under 5 Years Old in Lomé, Togo.

BACKGROUND: Pediatric bacterial meningitis (PBM) causes severe morbidity and mortality within Togo. Thus, as a member of the World Health Organization coordinated Invasive Bacterial Vaccine Preventable Diseases network, Togo conducts surveillance targeting Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae, at a sentinel hospital within the capital city, Lomé, in the southernmost Maritime region. METHODS: Cerebrospinal fluid was collected from children <5 years with suspected PBM admitted to the Sylvanus Olympio Teaching Hospital. Phenotypic detection of pneumococcus, meningococcus, and H. influenzae was confirmed through microbiological techniques. Samples were shipped to the Regional Reference Laboratory to corroborate results by species-specific polymerase chain reaction. RESULTS: Overall, 3644 suspected PBM cases were reported, and 98 cases (2.7%: 98/3644) were confirmed bacterial meningitis. Pneumococcus was responsible for most infections (67.3%: 66/98), followed by H. influenzae (23.5%: 23/98) and meningococcus (9.2%: 9/98). The number of pneumococcal meningitis cases decreased by 88.1% (52/59) postvaccine introduction with 59 cases from July 2010 to June 2014 and 7 cases from July 2014 to June 2016. However, 5 cases caused by nonvaccine serotypes were observed. Fewer PBM cases caused by vaccine serotypes were observed in infants <1 year compared to children 2-5 years. CONCLUSIONS: Routine surveillance showed that PCV13 vaccination is effective in preventing pneumococcal meningitis among children <5 years of age in the Maritime region. This complements the MenAfriVac vaccination against meningococcal serogroup A to prevent meningitis outbreaks in the northern region of Togo. Continued surveillance is vital for estimating the prevalence of PBM, determining vaccine impact, and anticipating epidemics in Togo

Reakcie nitrilov v koordinacnej sfere komplexov prechodnych prvkov

Available from Slovak Centre of Scientific and Technical Information, under shelf-number: A582782 / Slovenska Technicka Univerzita v BratislaveSIGLESKSlovak Republi

Aquabis(3-pyridylacrylato)-kappa O-2,O '; kappa O-bis(3-pyridylmethanol-kappa N)copper(II)

In the title complex, [Cu(C8H6NO2)(2)(C6H7NO)(2)(H2O)], the Cu2+ ion has a highly distorted square-bipyramidal (4 + 1 + 1) coordination environment, and is bonded to three carboxylate O atoms of two 3-pyridylacrylate anions (monodentate and asymetric bidentate), two pyridine N atoms of 3-pyridyl-methanol ligands and one water O atom. O-(HO)-O-... and O-(HN)-N-... hydrogen bonds result in the formation of a two-dimensional layer structure.</p

Etiology of Pediatric Bacterial Meningitis Pre- and Post-PCV13 Introduction Among Children Under 5 Years Old in Lomé, Togo

Abstract Background Pediatric bacterial meningitis (PBM) causes severe morbidity and mortality within Togo. Thus, as a member of the World Health Organization coordinated Invasive Bacterial Vaccine Preventable Diseases network, Togo conducts surveillance targeting Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae, at a sentinel hospital within the capital city, Lomé, in the southernmost Maritime region. Methods Cerebrospinal fluid was collected from children &lt;5 years with suspected PBM admitted to the Sylvanus Olympio Teaching Hospital. Phenotypic detection of pneumococcus, meningococcus, and H. influenzae was confirmed through microbiological techniques. Samples were shipped to the Regional Reference Laboratory to corroborate results by species-specific polymerase chain reaction. Results Overall, 3644 suspected PBM cases were reported, and 98 cases (2.7%: 98/3644) were confirmed bacterial meningitis. Pneumococcus was responsible for most infections (67.3%: 66/98), followed by H. influenzae (23.5%: 23/98) and meningococcus (9.2%: 9/98). The number of pneumococcal meningitis cases decreased by 88.1% (52/59) postvaccine introduction with 59 cases from July 2010 to June 2014 and 7 cases from July 2014 to June 2016. However, 5 cases caused by nonvaccine serotypes were observed. Fewer PBM cases caused by vaccine serotypes were observed in infants &lt;1 year compared to children 2–5 years. Conclusions Routine surveillance showed that PCV13 vaccination is effective in preventing pneumococcal meningitis among children &lt;5 years of age in the Maritime region. This complements the MenAfriVac vaccination against meningococcal serogroup A to prevent meningitis outbreaks in the northern region of Togo. Continued surveillance is vital for estimating the prevalence of PBM, determining vaccine impact, and anticipating epidemics in Togo. </jats:sec